公开(公告)号：US09134312B2

公开(公告)日：2015-09-15

申请号：US13148009

申请日：2010-02-05

申请人： Miguel Ängelo Da Costa Garcia ,  Carlos Jorge Sousa De São José ,  Clara Isabel Rodrigues Leandro ,  Filipa Maria Rodrigues Pardal Dias Antunes Marçal Da Silva ,  Sara Ferreira Llorente Grancho Lourenço

发明人： Miguel Ängelo Da Costa Garcia ,  Carlos Jorge Sousa De São José ,  Clara Isabel Rodrigues Leandro ,  Filipa Maria Rodrigues Pardal Dias Antunes Marçal Da Silva ,  Sara Ferreira Llorente Grancho Lourenço

IPC分类号： A61K39/00 ,  C07K14/005 ,  C12N7/00 ,  A01N63/00 ,  G01N33/569 ,  A61K35/76 ,  A61K45/06 ,  C12N9/64 ,  A61K38/00

CPC分类号： A61K35/76 ,  A61K9/0014 ,  A61K9/0073 ,  A61K38/00 ,  A61K45/06 ,  C07K14/005 ,  C12N7/00 ,  C12N9/6489 ,  C12N2795/00032 ,  C12N2795/10021 ,  C12N2795/10022 ,  C12N2795/10032 ,  C12N2795/14021 ,  C12N2795/14022 ,  C12N2795/14032 ,  G01N33/56911

摘要： The present invention is directed to the field of phage therapy for the treatment and control of bacterial infections. In particular, the present invention is directed to the novel bacteriophages F1245/05, F168/08, F170/08, F770/05, F197/08, F86/06, F87s/06 and F91a/06, isolated polypeptides thereof, compositions comprising one or more of the novel bacteriophages and/or isolated polypeptides and methods for the treatment and prevention of bacterial infection, either alone or in combination with other antibacterial therapies, e.g., antibiotics or other phage therapies.

摘要翻译： 本发明涉及用于治疗和控制细菌感染的噬菌体治疗领域。 特别地，本发明涉及新型噬菌体F1245 / 05，F168 / 08，F170 / 08，F770 / 05，F197 / 08，F86 / 06，F87s / 06和F91a / 06，其分离的多肽， 一种或多种新的噬菌体和/或分离的多肽和用于治疗和预防细菌感染的方法，单独或与其它抗菌疗法（例如抗生素或其它噬菌体疗法）结合使用。

公开(公告)号：US20120052048A1

公开(公告)日：2012-03-01

申请号：US13148009

申请日：2010-02-05

申请人： Miguel Ängelo Da Costa Garcia ,  Carlos Jorge Sousa De São José ,  Clara Isabel Rodrigues Leandro ,  Filipa Maria Rodrigues Pardal Dias Antunes Marçal Da Silva ,  Sara Ferreira Llorente Grancho Lourenço

发明人： Miguel Ängelo Da Costa Garcia ,  Carlos Jorge Sousa De São José ,  Clara Isabel Rodrigues Leandro ,  Filipa Maria Rodrigues Pardal Dias Antunes Marçal Da Silva ,  Sara Ferreira Llorente Grancho Lourenço

IPC分类号： A61K35/76 ,  C07K14/005 ,  A61K38/16 ,  A61P31/04 ,  A01N37/18 ,  C07H21/00 ,  C12Q1/70 ,  C12Q1/18 ,  A01N63/00 ,  C12N7/00 ,  A01P1/00

CPC分类号： A61K35/76 ,  A61K9/0014 ,  A61K9/0073 ,  A61K38/00 ,  A61K45/06 ,  C07K14/005 ,  C12N7/00 ,  C12N9/6489 ,  C12N2795/00032 ,  C12N2795/10021 ,  C12N2795/10022 ,  C12N2795/10032 ,  C12N2795/14021 ,  C12N2795/14022 ,  C12N2795/14032 ,  G01N33/56911

摘要： The present invention is directed to the field of phage therapy for the treatment and control of bacterial infections. In particular, the present invention is directed to the novel bacteriophages F1245/05, F168/08, F170/08, F770/05, F197/08, F86/06, F87s/06 and F91a/06, isolated polypeptides thereof, compositions comprising one or more of the novel bacteriophages and/or isolated polypeptides and methods for the treatment and prevention of bacterial infection, either alone or in combination with other antibacterial therapies, e.g., antibiotics or other phage therapies.

摘要翻译： 本发明涉及用于治疗和控制细菌感染的噬菌体治疗领域。 特别地，本发明涉及新型噬菌体F1245 / 05，F168 / 08，F170 / 08，F770 / 05，F197 / 08，F86 / 06，F87s / 06和F91a / 06，其分离的多肽， 一种或多种新的噬菌体和/或分离的多肽和用于治疗和预防细菌感染的方法，单独或与其它抗菌疗法（例如抗生素或其它噬菌体疗法）结合使用。